AVALYN PHARMACEUTICALS INC

Q2 2026 13F Holders

Symbol
AVLN
CUSIP
05348Y105
Type
Equity
Class
COM SHS
Num filings
94
Total reported value, excl. options
$1.46 B
Manager Report Date Value ($000) Shares Option Type